These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12942381)

  • 1. Interventions for visceral adiposity associated with human immunodeficiency virus: application of a method for assessing efficacy.
    Engelson ES
    Clin Infect Dis; 2003; 37 Suppl 2():S96-100. PubMed ID: 12942381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of fat partitioning in treated HIV-infection.
    Martínez E
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):415-27. PubMed ID: 21663836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat distribution in relation to drug use, human immunodeficiency virus (HIV) status, and the use of antiretroviral therapies in Hispanic patients with HIV infection.
    Forrester JE; Gorbach SL
    Clin Infect Dis; 2003; 37 Suppl 2():S62-8. PubMed ID: 12942376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle.
    Roubenoff R; Schmitz H; Bairos L; Layne J; Potts E; Cloutier GJ; Denry F
    Clin Infect Dis; 2002 Feb; 34(3):390-3. PubMed ID: 11774087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
    AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
    Bickel M; Zangos S; Jacobi V; Lutz T; Knecht G; Goebel F; Staszewski S; Klauke S
    HIV Med; 2006 Sep; 7(6):397-403. PubMed ID: 16903985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
    Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
    Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic therapy for HIV-associated lipodystrophy.
    Benavides S; Nahata MC
    Ann Pharmacother; 2004 Mar; 38(3):448-57. PubMed ID: 14755064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy.
    Johnson JA; Albu JB; Engelson ES; Fried SK; Inada Y; Ionescu G; Kotler DP
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E261-71. PubMed ID: 14532165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy.
    Bickel M; Eisen J; Stephan C; Crespi CM; Lutz T; Klauke S; Vogl TJ; Jacobi V; Yang OO; Staszewski S; Zangos S
    HIV Med; 2007 Oct; 8(7):413-9. PubMed ID: 17760732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.
    Ross R; Janssen I; Dawson J; Kungl AM; Kuk JL; Wong SL; Nguyen-Duy TB; Lee S; Kilpatrick K; Hudson R
    Obes Res; 2004 May; 12(5):789-98. PubMed ID: 15166299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
    Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution.
    Andersen O; Pedersen SB; Svenstrup B; Hansen BR; Paulsen SK; Rathje GS; Richelsen B; Nielsen JO; Madsbad S; Iversen J; Haugaard SB
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):250-8. PubMed ID: 17524033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body shape and composition in HIV-infected women: an urban cohort.
    Karmon SL; Moore RD; Dobs AS; Keruly J; Barnett S; Cofrancesco J
    HIV Med; 2005 Jul; 6(4):245-52. PubMed ID: 16011529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus-positive subjects: a cross-sectional study.
    Gavrila A; Tsiodras S; Doweiko J; Nagy GS; Brodovicz K; Hsu W; Karchmer AW; Mantzoros CS
    Clin Infect Dis; 2003 Jun; 36(12):1593-601. PubMed ID: 12802761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
    Cavalcanti RB; Raboud J; Shen S; Kain KC; Cheung A; Walmsley S
    J Infect Dis; 2007 Jun; 195(12):1754-61. PubMed ID: 17492590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.